These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 31280945

  • 1. Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice.
    Moser MJ, Hatta Y, Gabaglia C, Sanchez A, Dias P, Sarawar S, Kawaoka Y, Hatta M, Neumann G, Bilsel P.
    Vaccine; 2019 Jul 26; 37(32):4533-4542. PubMed ID: 31280945
    [Abstract] [Full Text] [Related]

  • 2. Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
    Rudenko L, Kiseleva I, Krutikova E, Stepanova E, Rekstin A, Donina S, Pisareva M, Grigorieva E, Kryshen K, Muzhikyan A, Makarova M, Sparrow EG, Torelli G, Kieny MP.
    PLoS One; 2018 Jul 26; 13(12):e0208028. PubMed ID: 30507951
    [Abstract] [Full Text] [Related]

  • 3. Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance.
    Skowronski DM, Hamelin ME, Janjua NZ, De Serres G, Gardy JL, Rhéaume C, Bouhy X, Boivin G.
    PLoS One; 2012 Jul 26; 7(6):e38929. PubMed ID: 22745690
    [Abstract] [Full Text] [Related]

  • 4. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
    Wan Z, Cardenas Garcia S, Liu J, Santos J, Carnaccini S, Geiger G, Ferreri L, Rajao D, Perez DR.
    J Virol; 2018 Nov 01; 92(21):. PubMed ID: 30135124
    [Abstract] [Full Text] [Related]

  • 5. Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity.
    Hatta Y, Boltz D, Sarawar S, Kawaoka Y, Neumann G, Bilsel P.
    Vaccine; 2018 Aug 09; 36(33):5097-5103. PubMed ID: 30007825
    [Abstract] [Full Text] [Related]

  • 6. N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies.
    Huang Y, Owino SO, Crevar CJ, Carter DM, Ross TM.
    J Virol; 2020 Feb 28; 94(6):. PubMed ID: 31852790
    [Abstract] [Full Text] [Related]

  • 7. Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
    Verma S, Soto J, Vasudevan A, Schmeisser F, Alvarado-Facundo E, Wang W, Weiss CD, Weir JP.
    PLoS One; 2017 Feb 28; 12(4):e0175733. PubMed ID: 28423025
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B.
    Gong X, Yin H, Shi Y, He X, Yu Y, Guan S, Kuai Z, Haji NM, Haji NM, Kong W, Shan Y.
    Emerg Microbes Infect; 2016 May 25; 5(5):e51. PubMed ID: 27222326
    [Abstract] [Full Text] [Related]

  • 9. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y, Boltz D, Sarawar S, Kawaoka Y, Neumann G, Bilsel P.
    Vaccine; 2017 Jul 24; 35(33):4177-4183. PubMed ID: 28668565
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of a qualified MDCK cell line for virus isolation to develop cell-based influenza vaccine viruses with appropriate antigenicity.
    Harada Y, Takahashi H, Fujimoto T, Horikoshi F, Chida S, Tanaka K, Minari K, Tanimoto Y, Fujisaki S, Miura H, Nakauchi M, Shimasaki N, Suzuki Y, Arita T, Hamamoto I, Yamamoto N, Hasegawa H, Odagiri T, Tashiro M, Nobusawa E.
    Vaccine; 2024 Oct 03; 42(23):126242. PubMed ID: 39213922
    [Abstract] [Full Text] [Related]

  • 11. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM, Allen JD, Bebin-Blackwell AG, Carter DM, Alefantis T, DiNapoli J, Kleanthous H, Ross TM.
    J Virol; 2017 Dec 15; 91(24):. PubMed ID: 28978710
    [Abstract] [Full Text] [Related]

  • 12. Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach.
    Sun W, Kirkpatrick E, Ermler M, Nachbagauer R, Broecker F, Krammer F, Palese P.
    J Virol; 2019 Jun 15; 93(12):. PubMed ID: 30944178
    [Abstract] [Full Text] [Related]

  • 13. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ, Gabbard JD, Li Z, Dlugolenski DA, Johnson SK, Tripp RA, He B, Tompkins SM.
    J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28931689
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
    Block SL, Yi T, Sheldon E, Dubovsky F, Falloon J.
    Vaccine; 2011 Nov 21; 29(50):9391-7. PubMed ID: 21983154
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan.
    Tsurudome Y, Kimachi K, Okada Y, Matsuura K, Ooyama Y, Ibaragi K, Kino Y, Ueda K.
    Microbiol Immunol; 2015 Oct 21; 59(10):597-604. PubMed ID: 26272602
    [Abstract] [Full Text] [Related]

  • 16. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P, Zheng M, Lau SY, Chen P, Mok BW, Liu S, Liu H, Huang X, Cremin CJ, Song W, Chen Y, Wong YC, Huang H, To KK, Chen Z, Xia N, Yuen KY, Chen H.
    mBio; 2019 Sep 17; 10(5):. PubMed ID: 31530680
    [Abstract] [Full Text] [Related]

  • 17. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD, Jang H, DiNapoli J, Kleanthous H, Ross TM.
    J Virol; 2019 Feb 01; 93(3):. PubMed ID: 30429350
    [Abstract] [Full Text] [Related]

  • 18. T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.
    Li J, Arévalo MT, Chen Y, Chen S, Zeng M.
    Int J Infect Dis; 2014 Oct 01; 27():37-43. PubMed ID: 25172265
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the vaccine-induced influenza B virus hemagglutinin-specific antibody dependent cellular cytotoxicity response.
    de Vries RD, Nieuwkoop NJ, Krammer F, Hu B, Rimmelzwaan GF.
    Virus Res; 2020 Feb 01; 277():197839. PubMed ID: 31837382
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.
    Kishida N, Fujisaki S, Yokoyama M, Sato H, Saito R, Ikematsu H, Xu H, Takashita E, Tashiro M, Takao S, Yano T, Suga T, Kawakami C, Yamamoto M, Kajiyama K, Saito H, Shimada S, Watanabe S, Aoki S, Taira K, Kon M, Lin JH, Odagiri T.
    Clin Vaccine Immunol; 2012 Jun 01; 19(6):897-908. PubMed ID: 22492743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.